Infectious Diseases

Infectious Diseases at Clinicalae

Clinicalae’s extensive Infectious Disease expertise enables us to consistently select the best sites, expedite start-up timelines, and achieve enrolment targets for our clients. We apply proven strategies to clinical trials that minimize risk and generate high-quality, reliable data, thereby reducing the time and cost of bringing new therapies to market.

Infectious Diseases Capabilities

Clinicalae’s Infectious Disease team understands the urgency, complexities, and potential challenges associated with infectious diseases. Most of our experienced Project Management and Clinical Operations team have extensive experience in infectious disease (ID) clinical research. We have conducted studies across a wide range of indications, including vaccines, antibacterials, antivirals, antifungals, pneumonia, and antiparasitics. Our team has also treated hospitalized patients with respiratory infections, including COVID-19, severe influenza, and pneumonia.

Why Choose Clinicalae?

By selecting Clinicalae as your contract research organization (CRO) partner, you will benefit from:

Experienced Leadership: Our leadership team, with well over 200 years of combined experience in infectious diseases clinical development, provides invaluable insights into protocols and strategies to operationalize execution.
Extensive Study Experience: We have conducted 129 infectious disease treatment studies in the past five years, including over 100 ongoing COVID-19 treatment studies and more than 100 antiviral studies for Hepatitis C, HIV, and Hepatitis B. Our antibacterial expertise covers bacterial infections, intra-abdominal, skin/soft tissue infections, and urinary infections.
Hospitalized Patient Studies: We have conducted over 40 studies within the past five years investigating infectious disease treatments in hospitalized patients.
Scalable COVID-19 Team: Our global COVID-19 team, including medical and drug development experts, is scalable and ready to be deployed.
Best Practices from Ongoing Studies: We apply best practices and learnings from our ongoing COVID-19 treatment studies to ensure the highest quality and efficiency in your trials.
Global Site Network (GSN): Our proprietary and vaccine-experienced Health Care Alliance (HCA) sites are prepared to conduct COVID-19 treatment trials.
FIRECREST Digital Solutions: Our learning and digital experts have considerable experience in developing engaging, study-focused content.

Join Us in Transforming Healthcare

We invite you to be a part of the healthcare revolution. Collaborate with us to drive innovation, improve patient outcomes, and shape the future of healthcare. Together, let’s make a difference in the lives of millions.